An innovative approach to integrated medicines management

Area of Science:

• Clinical Pharmacy
• Health Services Research
• Patient Care Management

Background:

• Medicines management is crucial for patients at risk of drug-related problems.
• Hospital journeys involve multiple stages requiring coordinated pharmaceutical care.
• Existing hospital care models may not fully address comprehensive medication management.

Purpose of the Study:

• To evaluate the impact of integrated medicines management (IMM) services on patient care.
• To assess clinical and economic outcomes associated with enhanced pharmacist input.
• To determine if IMM improves patient care from admission through discharge.

Main Methods:

• A randomized controlled trial comparing IMM service with regular hospital care.
• Patients at risk of drug-related problems were assigned to either IMM or usual care.
• IMM involved comprehensive pharmaceutical care across admission, inpatient, and discharge stages.

Main Results:

• IMM service reduced hospital length of stay by 2 days (P=0.003).
• IMM patients showed a decreased 12-month readmission rate (40.8% vs 49.3%, p=0.027).
• Time to readmission was 20 days longer for IMM patients (P=0.0356), preventing one readmission per 12 patients.

Conclusions:

• Integrated medicines management services are highly effective in improving patient outcomes.
• The IMM model can serve as a template for implementing comprehensive pharmaceutical care routinely.
• The service was positively received by healthcare professionals, indicating potential for wider adoption.